BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17401091)

  • 1. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.
    Kudo Y; Okamura N; Furumoto S; Tashiro M; Furukawa K; Maruyama M; Itoh M; Iwata R; Yanai K; Arai H
    J Nucl Med; 2007 Apr; 48(4):553-61. PubMed ID: 17401091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.
    Furukawa K; Okamura N; Tashiro M; Waragai M; Furumoto S; Iwata R; Yanai K; Kudo Y; Arai H
    J Neurol; 2010 May; 257(5):721-7. PubMed ID: 19946781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease.
    Kudo Y
    Minim Invasive Ther Allied Technol; 2006; 15(4):209-13. PubMed ID: 16966133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 18F-labeled BF-227 derivative as a potential radioligand for imaging dense amyloid plaques by positron emission tomography.
    Furumoto S; Okamura N; Furukawa K; Tashiro M; Ishikawa Y; Sugi K; Tomita N; Waragai M; Harada R; Tago T; Iwata R; Yanai K; Arai H; Kudo Y
    Mol Imaging Biol; 2013 Aug; 15(4):497-506. PubMed ID: 23362000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voxel-based analysis of amyloid positron emission tomography probe [C]BF-227 uptake in mild cognitive impairment and alzheimer's disease.
    Shao H; Okamura N; Sugi K; Furumoto S; Furukawa K; Tashiro M; Iwata R; Matsuda H; Kudo Y; Arai H; Fukuda H; Yanai K
    Dement Geriatr Cogn Disord; 2010; 30(2):101-11. PubMed ID: 20733303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel imaging probe for in vivo detection of neuritic and diffuse amyloid plaques in the brain.
    Okamura N; Suemoto T; Shiomitsu T; Suzuki M; Shimadzu H; Akatsu H; Yamamoto T; Arai H; Sasaki H; Yanai K; Staufenbiel M; Kudo Y; Sawada T
    J Mol Neurosci; 2004; 24(2):247-55. PubMed ID: 15456938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
    Okamura N; Suemoto T; Shimadzu H; Suzuki M; Shiomitsu T; Akatsu H; Yamamoto T; Staufenbiel M; Yanai K; Arai H; Sasaki H; Kudo Y; Sawada T
    J Neurosci; 2004 Mar; 24(10):2535-41. PubMed ID: 15014129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.
    Kaneta T; Okamura N; Minoshima S; Furukawa K; Tashiro M; Furumoto S; Iwata R; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
    Ann Nucl Med; 2011 Dec; 25(10):732-9. PubMed ID: 21792587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between β-amyloid deposits revealed by BF-227-PET imaging and brain atrophy detected by voxel-based morphometry-MR imaging: a pilot study.
    Maeno N
    Nucl Med Commun; 2019 Sep; 40(9):905-912. PubMed ID: 31246935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls of voxel-based amyloid PET analyses for diagnosis of Alzheimer's disease: artifacts due to non-specific uptake in the white matter and the skull.
    Arai A; Kaneta T; Okamura N; Tashiro M; Iwata R; Takanami K; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
    Tohoku J Exp Med; 2014 Nov; 234(3):175-81. PubMed ID: 25311079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
    Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G
    Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid imaging in Alzheimer's disease.
    Nordberg A
    Curr Opin Neurol; 2007 Aug; 20(4):398-402. PubMed ID: 17620873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
    Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical and clinical study on [
    Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ¹⁸F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in Alzheimer's disease.
    Cui M; Ono M; Kimura H; Ueda M; Nakamoto Y; Togashi K; Okamoto Y; Ihara M; Takahashi R; Liu B; Saji H
    J Med Chem; 2012 Nov; 55(21):9136-45. PubMed ID: 22690944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET.
    Okamura N; Shiga Y; Furumoto S; Tashiro M; Tsuboi Y; Furukawa K; Yanai K; Iwata R; Arai H; Kudo Y; Itoyama Y; Doh-ura K
    Eur J Nucl Med Mol Imaging; 2010 May; 37(5):934-41. PubMed ID: 20016895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.
    Ito H; Shinotoh H; Shimada H; Miyoshi M; Yanai K; Okamura N; Takano H; Takahashi H; Arakawa R; Kodaka F; Ono M; Eguchi Y; Higuchi M; Fukumura T; Suhara T
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):745-54. PubMed ID: 24233004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease.
    Waragai M; Okamura N; Furukawa K; Tashiro M; Furumoto S; Funaki Y; Kato M; Iwata R; Yanai K; Kudo Y; Arai H
    J Neurol Sci; 2009 Oct; 285(1-2):100-8. PubMed ID: 19552926
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.